Mindfulness and Qigong program for COVID-19 survivors and caregivers
Developing an Integrated Mindfulness-based Health Qigong Intervention (iMBHQ) for COVID-19 Survivors and Caregivers to Improve Their Physical and Psychological Wellness
This study is testing a 16-week mindfulness and Qigong program to see if it can help COVID-19 survivors and their caregivers feel better both physically and mentally.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Hong Kong Polytechnic University Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06194357 on ClinicalTrials.gov |
What this trial studies
This study examines the effectiveness of an integrated mindfulness-based health Qigong intervention (iMBHQ) aimed at improving the physical and psychological wellness of COVID-19 survivors, caregivers, and the general public. Participants will be randomized into a treatment group, which will undergo a 16-week program consisting of an initial face-to-face session followed by bi-weekly online mindfulness sessions and daily Qigong practice. Follow-up assessments will occur every six months for two years to evaluate the long-term benefits of the intervention. The study seeks to address the mental health challenges faced by individuals affected by COVID-19.
Who should consider this trial
Good fit: Ideal candidates include COVID-19 survivors aged 18 and above, caregivers of COVID-19 patients, and healthy individuals from the general public.
Not a fit: Patients with severe psychiatric disorders or chronic conditions that hinder participation in Qigong or mindfulness practices may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the mental and physical well-being of COVID-19 survivors and their caregivers.
How similar studies have performed: Other studies have shown positive outcomes with mindfulness-based interventions, suggesting potential success for this integrated approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * COVID-19 survivors: people aged 18 years or above who were infected by COVID-19 (both symptomatic and asymptomatic) and clinically recovered * Caregivers of COVID-19 patients, including family members or medical professionals who have contacts with patients diagnosed COVID-19 aged 18 years or above * General healthy public aged 18 years or above Exclusion Criteria: * people diagnosed severe and/or chronic conditions that prevent the practice of Qigong (e.g., acute exacerbation of dyspnoea, severe cardiopulmonary disease) or mindfulness intervention, * people with severe psychiatric disorder * people who have regular psychiatric follow-ups
Where this trial is running
Hong Kong
- Princess Margaret Hospital — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Wing Hong, Hector TSANG, Prof — Department of Rehabilitation Science, Faculty of Health and Social Sciences
- Study coordinator: Travis,Tsz-kwun Law, Mr
- Email: tk120@ha.org.hk
- Phone: 29901017
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.